Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression von Croucher, Danielle C., Richards, Laura M., Tsofack, Serges P., Waller, Daniel, Li, Zhihua, Wei, Ellen Nong, Huang, Xian Fang, Chesi, Marta, Bergsagel, P. Leif, Sebag, Michael, Pugh, Trevor J., Trudel, Suzanne

Volltext

Disrupting Mitohormesis As a Novel Therapeutic Strategy for Multiple Myeloma (MM) Including Those with High Risk Disease and Proteosome Inhibitor Resistance von Tsofack, Serges P, Croucher, Danielle C, Barwick, Benjamin G, Li, Zhihua, Aman, Ahmed, Tao, Dennis, Wei, Ellen nong, Garcia Prat, Laura, Schimmer, Aaron D, Trudel, Suzanne

Volltext

Selective Cell State in the Clonally Expanded T-Cell Compartment of VκMYC Mice Responding to Treatment with Checkpoint Inhibitors von Croucher, Danielle C, Richards, Laura M, Li, Zhihua, Wei, Ellen nong, Huang, Xian Fang, Waller, Daniel, Chesi, Marta, Bergsagel, P. Leif, Sebag, Michael, Pugh, Trevor J., Trudel, Suzanne

Volltext

Abstract 5489: Characterization of mitochondrial STAT3 (mitostat3) function and the mitoStat3 interactome as a therapeutic strategy for multiple myeloma von Tsofack, Serges P., Botham, Aaron, Li, Zhihua, Wei, Ellen Nong, Croucher, Danielle, Jitkova, Ioulia, MacLean, Neil, Schimmer, Aaron D., Raught, Brian, Trudel, Suzanne

Volltext

Long‐term follow‐up of a phase 2 trial of single agent lenalidomide in previously untreated patients with chronic lymphocytic leukaemia von Chen, Christine I., Paul, Harminder, Wang, Trina, Le, Lisa W., Dave, Nimisha, Kukreti, Vishal, Nong Wei, Ellen, Lau, Anthea, Bergsagel, Peter Leif, Trudel, Suzanne

Volltext

A Novel Small Molecule STAT Inhibitor, BP-4-018, Demonstrates Significant Anti-Tumour Activity and Synergism With Bortezomib In Pre-Clinical In Vivo Models Of Multiple Myeloma von Croucher, Danielle C, Li, Zhihua, Page, Brent D.G., Wei, Ellen Nong, Gunning, Patrick T., Trudel, Suzanne

Volltext

An Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL) von Chen, Christine I, Paul, Harminder, Snitzler, Susi, Le, Lisa W, Wei, Ellen Nong, Lau, Anthea, Johnston, James B, Gibson, Spencer B., Queau, Michelle L., Trudel, Suzanne

Volltext

Biomarker Driven Phase II Clinical Trial of Trametinib in Relapsed/Refractory Multiple Myeloma with Sequential Addition of the AKT Inhibitor, GSK2141795 at Time of Disease Progress... von Trudel, Suzanne, Bahlis, Nizar J., Venner, Christopher P., Hay, Annette E, Kis, Olena, Chow, Signy, Li, Zhi Hua, Wei, Ellen Nong, Wang, Lisa, Tran, Christine, Udagani, Smitha, Blattler, Chantale, Pugh, Trevor J., Chen, Helen X, Oza, Amit

Volltext

A Phase 2 Study of Ofatumumab in Combination with a Pan-AKT Inhibitor (Afuresertib) in Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL) von Chen, Christine I, Snitzler, Susi, Levina, Olga, Wang, Tong (Trina), Le, Lisa W, Paul, Harminder, Wei, Ellen Nong, Lau, Anthea, Queau, Michelle, Johnston, James B, Trudel, Suzanne, Smith, Deborah A

Volltext

An Open-Label Phase 2 Study Of Ofatumumab In Combination With a Novel AKT Inhibitor (Afuresertib) In Previously Treated Patients With Chronic Lymphocytic Leukemia (CLL) von Chen, Christine I., Snitzler, Susi, Wang, Trina, Paul, Harminder, Le, Lisa W, Wei, Ellen Nong, Lau, Anthea, Smith, Deborah A, Brown, Michelle, Johnston, James B, Trudel, Suzanne

Volltext

An Open-Label Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in the Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL) von Chen, Christine, Paul, Harminder, Del Rizzo, Luisa, Le, Lisa W, Wei, Ellen Nong, Lau, Anthea, Johnston, James B, Gibson, Spencer B, Brown, Michelle, Trudel, Suzanne

Volltext

Long-Term Follow-up of a Phase 2 Study of Single Agent Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL) von Chen, Christine, Paul, Harminder, Wang, Trina, Le, Lisa W, Kukreti, Vishal, Wei, Ellen Nong, Lau, Anthea, Bergsagel, P. Leif, Dave, Nimisha, Trudel, Suzanne

Volltext

GSK-3 Spatial Regulation Has an Essential Role in Lenalidomide Activity and Represents a Biomarker of Clinical Response in CLL von Trudel, Suzanne, Scanga, Sam, Mastronardi, Fabrizio G, Wei, Ellen Nong, Mercurio, Frank, Lopez-Girona, Antonia, Gaidarova, Svetlana, Webb, David R., Chen, Christine, Stewart, Keith, Manoukian, Armen S

Volltext